Max India Reports 15% Revenue Growth in H1 FY26, Raises INR 204 Crores for Expansion
Max India Limited reported a 15% year-on-year growth in consolidated revenue for H1 FY26, reaching INR 91.5 crores. Q2 FY26 revenue was INR 50.20 crores, up 6% YoY. The company successfully raised INR 204.23 crores through rights issue and preferential warrants. Care Homes occupancy improved to 25% in Q2, with 340 operational beds out of 490. Care at Home achieved its highest quarterly revenue of INR 5.24 crores. AGEasy reported INR 20.90 crores net revenue in Q2 FY26. Max India plans to expand Care Homes to 500 operational beds by November end and aims to scale AGEasy to breakeven by early FY28 or late FY27.

*this image is generated using AI for illustrative purposes only.
Max India Limited , a prominent player in the senior care sector, has reported a robust 15% year-on-year growth in consolidated revenue for the first half of fiscal year 2026, reaching INR 91.5 crores. The company's strategic expansion across its senior care verticals, including Care Homes, Care at Home, and AGEasy products, has been the primary driver of this growth.
Financial Highlights
- Consolidated revenue for H1 FY26: INR 91.50 crores (15% YoY growth)
- Q2 FY26 revenue: INR 50.20 crores (6% YoY growth)
- Successful capital raise: INR 204.23 crores
- Rights issue: INR 124.23 crores
- Preferential warrants: INR 80.00 crores
Operational Performance
Care Homes
- Occupancy improved from 20% in Q1 FY26 to 25% in Q2 FY26
- 490 beds in place, with 340 operational
- Average Revenue Per Occupied Bed (ARPOB): INR 6,000 to INR 6,500
Care at Home
- Highest quarterly revenue of INR 5.24 crores (1.1x QoQ and 1.3x YoY growth)
- Improved margins in Bengaluru and Chennai
AGEasy
- Net revenue of INR 20.90 crores in Q2 FY26
- Monthly run rate of INR 7-8 crores
- H1 FY26 revenue: INR 35.00 crores (3.3x growth YoY)
- Return on Ad Spend (RoAS) improved to 2, marking 1.1x QoQ and 1.3x YoY growth
Strategic Initiatives
Max India has outlined several key initiatives to drive future growth:
Residential Projects: The company aims to develop 1.5 million square feet annually, with plans to launch a new project, E361, in December 2025.
Care Homes Expansion: Max India plans to have 500 operational beds by November end, with further expansion planned over the next four years.
AGEasy Growth: The company is focusing on scaling AGEasy to reach breakeven by early FY28 or late FY27.
Product Innovation: Max India has filed 4 patents for AGEasy products and is launching a Gut Health nutraceutical range.
Marketing Efficiency: The company has seen improved conversion rates and click-through rates on Google following celebrity partnerships.
Management Commentary
Rajit Mehta, Managing Director of Max India, stated, "Q2 and H1 FY26 reflect a very pivotal period. The scale-up was indeed exponential for this year, but we are glad that all the transition we had wanted, execution, foundation setting for scale has been done."
Outlook
While Max India does not provide forward-looking statements, the company's focus on cost optimization, high utilization, and efficient treasury management suggests a continued emphasis on improving profitability. The company's diverse portfolio across senior care verticals positions it well to capitalize on the growing demand in the sector.
Max India's strategic capital raise of INR 204.23 crores through rights issues and preferential warrants demonstrates investor confidence and provides the company with the necessary funds to support its ambitious growth plans across its senior care verticals.
As the senior care sector in India continues to evolve rapidly, Max India's multi-pronged approach to growth and its focus on operational efficiency may position it favorably in this expanding market.
Historical Stock Returns for Max India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.86% | -6.25% | -8.27% | +5.89% | -10.82% | +255.37% |









































